These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20197483)

  • 1. Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
    Campregher C; Honeder C; Chung H; Carethers JM; Gasche C
    Clin Cancer Res; 2010 Mar; 16(6):1950-6. PubMed ID: 20197483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair.
    Chung H; Lopez CG; Holmstrom J; Young DJ; Lai JF; Ream-Robinson D; Carethers JM
    Hum Mol Genet; 2010 Jul; 19(13):2638-47. PubMed ID: 20418486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine improves replication fidelity in cultured colorectal cells.
    Gasche C; Goel A; Natarajan L; Boland CR
    Cancer Res; 2005 May; 65(10):3993-7. PubMed ID: 15899787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
    Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
    PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells.
    Campregher C; Scharl T; Nemeth M; Honeder C; Jascur T; Boland CR; Gasche C
    Hum Mol Genet; 2010 Jul; 19(13):2648-57. PubMed ID: 20421367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2).
    Chung H; Chaudhry J; Lai JF; Young DJ; Carethers JM
    Mutat Res; 2012 Jan; 729(1-2):73-80. PubMed ID: 22001236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
    Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
    Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
    Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.
    Luciani MG; Campregher C; Fortune JM; Kunkel TA; Gasche C
    Gastroenterology; 2007 Jan; 132(1):221-35. PubMed ID: 17241873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.
    Tougeron D; Fauquembergue E; Rouquette A; Le Pessot F; Sesboüé R; Laurent M; Berthet P; Mauillon J; Di Fiore F; Sabourin JC; Michel P; Tosi M; Frébourg T; Latouche JB
    Mod Pathol; 2009 Sep; 22(9):1186-95. PubMed ID: 19503063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
    Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
    Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
    Raeker MÖ; Pierre-Charles J; Carethers JM
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM; Pham TT
    In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.
    Lee J; Ballikaya S; Schönig K; Ball CR; Glimm H; Kopitz J; Gebert J
    PLoS One; 2013; 8(2):e57074. PubMed ID: 23468914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.
    Kortüm B; Campregher C; Lang M; Khare V; Pinter M; Evstatiev R; Schmid G; Mittlböck M; Scharl T; Kucherlapati MH; Edelmann W; Gasche C
    Gut; 2015 Dec; 64(12):1905-12. PubMed ID: 25429050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.
    Campregher C; Luciani MG; Biesenbach P; Evstatiev R; Lyakhovich A; Gasche C
    Inflamm Bowel Dis; 2010 Apr; 16(4):576-82. PubMed ID: 19821510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of frame-shift intermediate mutant cells.
    Gasche C; Chang CL; Natarajan L; Goel A; Rhees J; Young DJ; Arnold CN; Boland CR
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1914-9. PubMed ID: 12578960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.
    Jung B; Smith EJ; Doctolero RT; Gervaz P; Alonso JC; Miyai K; Keku T; Sandler RS; Carethers JM
    Int J Cancer; 2006 May; 118(10):2509-13. PubMed ID: 16380996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
    de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
    Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas.
    Samowitz WS; Slattery ML
    Am J Pathol; 1997 Jul; 151(1):33-5. PubMed ID: 9212728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.